Although we can potentially extrapolate to suggest that this is also the case in normal ERα+ luminal progenitors, because ChIP studies are only possible in ER+ breast cancer cells, we cannot exclude the possibility that estrogen signaling could indirectly regulate H19 transcription and expression in healthy ER+ luminal progenitors. The gene discussed is H19; the disease is breast carcinoma.